Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 2
2002 5
2003 2
2004 1
2005 5
2006 1
2007 7
2008 9
2009 6
2010 9
2011 9
2012 15
2013 11
2014 13
2015 19
2016 12
2017 15
2018 13
2019 16
2020 9
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 25760884

158 results
Results by year
Filters applied: . Clear all
Page 1
Serum osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection.
Matsue Y, Tsutsumi M, Hayashi N, Saito T, Tsuchishima M, Toshikuni N, Arisawa T, George J. Matsue Y, et al. PLoS One. 2015 Mar 11;10(3):e0118744. doi: 10.1371/journal.pone.0118744. eCollection 2015. PLoS One. 2015. PMID: 25760884 Free PMC article.
Elevated serum osteopontin levels in chronic hepatitis C virus infection: association with autoimmune rheumatologic manifestations.
Bassyouni IH, Bassyouni RH, Ibrahim NH, Soliman AF. Bassyouni IH, et al. J Clin Immunol. 2012 Dec;32(6):1262-9. doi: 10.1007/s10875-012-9727-7. Epub 2012 Jun 24. J Clin Immunol. 2012. PMID: 22730056
Plasma osteopontin concentration correlates with the severity of hepatic fibrosis and inflammation in HCV-infected subjects.
Huang W, Zhu G, Huang M, Lou G, Liu Y, Wang S. Huang W, et al. Clin Chim Acta. 2010 May 2;411(9-10):675-8. doi: 10.1016/j.cca.2010.01.029. Epub 2010 Feb 2. Clin Chim Acta. 2010. PMID: 20138033
The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease.
Patouraux S, Bonnafous S, Voican CS, Anty R, Saint-Paul MC, Rosenthal-Allieri MA, Agostini H, Njike M, Barri-Ova N, Naveau S, Le Marchand-Brustel Y, Veillon P, Calès P, Perlemuter G, Tran A, Gual P. Patouraux S, et al. PLoS One. 2012;7(4):e35612. doi: 10.1371/journal.pone.0035612. Epub 2012 Apr 18. PLoS One. 2012. PMID: 22530059 Free PMC article.
Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis C.
Shlomai A, Halfon P, Goldiner I, Zelber-Sagi S, Halpern Z, Oren R, Bruck R. Shlomai A, et al. J Viral Hepat. 2013 Feb;20(2):95-102. doi: 10.1111/j.1365-2893.2012.01628.x. Epub 2012 Aug 3. J Viral Hepat. 2013. PMID: 23301544
Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Muga R. Sanvisens A, et al. J Viral Hepat. 2009 Jul;16(7):513-8. doi: 10.1111/j.1365-2893.2009.01103.x. Epub 2009 Feb 5. J Viral Hepat. 2009. PMID: 19200132
Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus.
Sobhy A, Fakhry M M, A Azeem H, Ashmawy AM, Omar Khalifa H. Sobhy A, et al. J Investig Med. 2019 Mar;67(3):681-685. doi: 10.1136/jim-2018-000840. Epub 2018 Oct 31. J Investig Med. 2019. PMID: 30385593
A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI).
Ahmad W, Ijaz B, Javed FT, Gull S, Kausar H, Sarwar MT, Asad S, Shahid I, Sumrin A, Khaliq S, Jahan S, Pervaiz A, Hassan S. Ahmad W, et al. BMC Gastroenterol. 2011 Apr 21;11:44. doi: 10.1186/1471-230X-11-44. BMC Gastroenterol. 2011. PMID: 21507271 Free PMC article.
Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease.
Saitou Y, Shiraki K, Yamanaka Y, Yamaguchi Y, Kawakita T, Yamamoto N, Sugimoto K, Murata K, Nakano T. Saitou Y, et al. World J Gastroenterol. 2005 Jan 28;11(4):476-81. doi: 10.3748/wjg.v11.i4.476. World J Gastroenterol. 2005. PMID: 15641129 Free PMC article.
Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
El Raziky M, Attia D, El Akel W, Shaker O, Khatab H, Abdo S, Elsharkawy A, Esmat G. El Raziky M, et al. Arab J Gastroenterol. 2013 Sep;14(3):94-8. doi: 10.1016/j.ajg.2013.08.005. Epub 2013 Oct 10. Arab J Gastroenterol. 2013. PMID: 24206736
158 results
Jump to page
Feedback